The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.

A specific class of antidepressant medications -- selective serotonin reuptake inhibitors -- actually might speed up brain ...

For the last six weeks, the shadow of potential layoffs has hung over Repare Therapeutics’ employees. Monday, staff learned ...

Dermatologists are practicing in an “era of good efficacy” of nonsteroidal topical therapies for psoriasis, and they can help patients access newer topical medications by working with pharmacies that ...

Scale Biosciences (Scale Biotm), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell RNA kits, a set of next-generation ...

The global Heart Failure Drugs Market is valued at $8.6 billion in 2024 and is projected to reach a value of $21.4 billion by 2035. This growth represents a Compound Annual Growth Rate (CAGR) of 12.1% ...

Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) ...

The Boiler Water Treatment Chemicals Market grows as industries adopt advanced solutions for efficiency, equipment longevity, and sustaina ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...

This finding is especially interesting because the same drug was less effective at lowering blood sugar levels in older ...

Advanced Machine Learning Models for Gender-Specific Antidepressant Response Prediction: Overcoming Data Imbalance for Precision Psychiatry Depressive disorders are complex, multifactorial conditions ...